San Diego-dependent Viking Therapeutics marked alone as a significant competitor in the weight loss drug current market in February right after revealing promising knowledge from a mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when supplied being a weekly injection and in March the co